HARVARD BIOSCIENCE INC Goodwill & Intangibles Disclosure
|
5. |
Goodwill and Intangible Assets |
The change in the carrying amount of goodwill was as follows:
|
December 31, |
||||||||
|
(in thousands) |
2025 |
2024 |
||||||
|
Carrying amount at beginning of period |
$ | 56,324 | $ | 57,065 | ||||
|
Goodwill impairment |
(47,951 | ) | - | |||||
|
Effect of change in currency translation |
1,186 | (741 | ) | |||||
|
Carrying amount at end of period |
$ | 9,559 | $ | 56,324 | ||||
Intangible assets, net at December 31, 2025 and 2024 consisted of the following:
|
December 31, 2025 |
December 31, 2024 |
|||||||||||||||||||||||||||
|
(in thousands) |
Average |
Accumulated |
Accumulated |
|||||||||||||||||||||||||
|
Amortizable intangible assets: |
Life* |
Gross |
Amortization |
Net |
Gross |
Amortization |
Net |
|||||||||||||||||||||
|
Customer relationships |
4 | $ | 16,378 | $ | (12,119 | ) | $ | 4,259 | $ | 15,603 | $ | (10,450 | ) | $ | 5,153 | |||||||||||||
|
Technology and software development |
1 | 36,398 | (33,801 | ) | 2,597 | 35,397 | (30,556 | ) | 4,841 | |||||||||||||||||||
|
Trade names and patents |
1 | 7,732 | (7,168 | ) | 564 | 7,452 | (6,509 | ) | 943 | |||||||||||||||||||
|
Total amortizable intangible assets |
$ | 60,508 | $ | (53,088 | ) | $ | 7,420 | $ | 58,452 | $ | (47,515 | ) | $ | 10,937 | ||||||||||||||
|
Indefinite-lived intangible assets: |
219 | 195 | ||||||||||||||||||||||||||
|
Total intangible assets |
$ | 7,639 | $ | 11,132 | ||||||||||||||||||||||||
|
* Weighted average life in years as of December 31, 2025 |
||||||||||||||||||||||||||||
The Company capitalized $0.6 million and $0.6 million of software development costs during the year ended December 31, 2025, and 2024, respectively.
Intangible asset amortization expense was $4.2 million and $5.4 million for the years ended December 31, 2025 and 2024, respectively.
|
Year Ended December 31, |
||||||||
|
(in thousands) |
2025 |
2024 |
||||||
|
Cost of revenues |
$ | 175 | $ | 175 | ||||
|
Operating expense |
4,027 | 5,255 | ||||||
|
Total amortization of intangible assets |
$ | 4,202 | $ | 5,430 | ||||
Estimated amortization expense of existing amortizable intangible assets for each of the five succeeding years and thereafter is as follows:
|
(in thousands) |
||||
|
2026 |
$ | 2,955 | ||
|
2027 |
1,683 | |||
|
2028 |
1,436 | |||
|
2029 |
950 | |||
|
2030 |
396 | |||
|
Thereafter |
- | |||
|
Total |
$ | 7,420 |
Want the next HARVARD BIOSCIENCE INC goodwill & intangibles disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment HARVARD BIOSCIENCE INC's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 13, 2026 | Showing above |
| 2024 | Mar 14, 2025 | |
| 2023 | Mar 7, 2024 | |
| 2022 | Mar 9, 2023 | |
| 2021 | Mar 11, 2022 | |
| 2020 | Mar 12, 2021 | |
| 2019 | Mar 16, 2020 | |
| 2018 | Mar 18, 2019 | |
| 2017 | Mar 16, 2018 | |
| 2016 | Mar 17, 2017 | |
| 2015 | Apr 29, 2016 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.